The official website for European football

UEFA Football Doctor Education Programme

UEFA Football Doctor Education Programme
Participants at a UEFA Football Doctor Education Programme workshop ©Getty Images


UEFA's Football Doctor Education Programme is designed for doctors from every European FA to receive education and instruction in the specific field of football medicine.

Expert football medical knowledge – a crucial factor in the game – is available to UEFA's member national associations. The programme aims to set new standards through the dissemination of this specific knowledge throughout European football.

The course – the UEFA Football Doctor Education Programme – comes under the auspices of UEFA's Knowledge & Information Sharing Scenario (KISS). It seeks to benefit the entire continental game by facilitating, harmonising and spreading football medicine know-how across UEFA's member associations.

The programme offers a unique combination of education and instruction in all key areas of the role of the modern football doctor, including emergency treatment of players, injury prevention, treatment and rehabilitation, the roles and responsibilities of the football doctor, and anti-doping.

Participants are required to attend three workshops of three to four days' duration over a period of three years (one a year) and will complete various online (elearning) modules.

The programme topics:

Roles and responsibilities of the doctor
Overview of the general skills and knowledge needed by the modern team doctor

Emergency treatment of players
Instruction on advanced techniques for managing the treatment of serious and life-threatening on-field injury

Injury prevention
Insight into the findings and practical outcomes of the UEFA Injury Study, one of the world's largest and longest-running sports injury studies

Treatment and rehabilitation
Key factors contributing to effective treatment and rehabilitation of football injuries

Role of the team doctor in the anti-doping process, including testing, whereabouts and therapeutic use exemption procedures